HB Wealth Management LLC Buys 1,499 Shares of Intuitive Surgical, Inc. $ISRG

HB Wealth Management LLC lifted its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 5.7% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 27,772 shares of the medical equipment provider’s stock after purchasing an additional 1,499 shares during the quarter. HB Wealth Management LLC’s holdings in Intuitive Surgical were worth $15,729,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds have also recently made changes to their positions in ISRG. Rakuten Investment Management Inc. bought a new position in shares of Intuitive Surgical during the third quarter valued at $388,436,000. Assenagon Asset Management S.A. increased its holdings in shares of Intuitive Surgical by 106.6% during the fourth quarter. Assenagon Asset Management S.A. now owns 1,533,771 shares of the medical equipment provider’s stock valued at $868,667,000 after acquiring an additional 791,516 shares in the last quarter. Amundi increased its holdings in shares of Intuitive Surgical by 29.7% during the third quarter. Amundi now owns 3,227,472 shares of the medical equipment provider’s stock valued at $1,451,362,000 after acquiring an additional 739,444 shares in the last quarter. Sands Capital Management LLC increased its holdings in shares of Intuitive Surgical by 77.0% during the third quarter. Sands Capital Management LLC now owns 1,341,109 shares of the medical equipment provider’s stock valued at $599,784,000 after acquiring an additional 583,539 shares in the last quarter. Finally, Victory Capital Management Inc. lifted its stake in shares of Intuitive Surgical by 41.3% in the third quarter. Victory Capital Management Inc. now owns 1,941,310 shares of the medical equipment provider’s stock worth $868,212,000 after buying an additional 567,483 shares in the last quarter. 83.64% of the stock is owned by institutional investors.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, SVP Mark Brosius sold 645 shares of the stock in a transaction dated Monday, March 9th. The stock was sold at an average price of $485.01, for a total value of $312,831.45. Following the transaction, the senior vice president owned 1,613 shares of the company’s stock, valued at approximately $782,321.13. This represents a 28.57% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, VP Fredrik Widman sold 133 shares of the business’s stock in a transaction that occurred on Wednesday, February 11th. The shares were sold at an average price of $494.96, for a total transaction of $65,829.68. Following the sale, the vice president owned 660 shares of the company’s stock, valued at $326,673.60. This trade represents a 16.77% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last 90 days, insiders sold 32,943 shares of company stock worth $17,279,568. Company insiders own 0.60% of the company’s stock.

Intuitive Surgical News Summary

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Q1 results materially beat expectations — revenue $2.77B (+23% y/y) and non‑GAAP EPS $2.50 vs. consensus ~$2.08; company raised its full‑year procedure growth guidance, which underpins upside to recurring instrument/consumable sales. Why Intuitive Surgical (ISRG) Stock Is Up Today
• Positive Sentiment: Procedure and platform adoption remain the growth engine: da Vinci procedures grew ~16%, Ion procedures ~39%, and management highlighted placements/usage for the new da Vinci 5 — supporting longer‑term recurring revenue. Intuitive Announces First Quarter Earnings
• Positive Sentiment: Analysts reacted by raising some forecasts and price targets (Goldman, Baird among those nudging targets higher), and several firms reiterated Buy/Outperform ratings after the beat — providing further near‑term support. Intuitive Surgical Analysts Boost Their Forecasts After Upbeat Q1 Earnings
• Positive Sentiment: Management emphasized expansion of digital and AI‑enabled surgical capabilities and secured new FDA clearances — strategic catalytic items for long‑term TAM expansion and higher‑margin software/services revenue. Intuitive Surgical Balances Growth In AI Surgery With Cybersecurity Lessons
• Neutral Sentiment: Earnings call color: management raised its 2026 da Vinci procedure growth guide (roughly 13.5%–15.5%) and described international headwinds as manageable — positive directional detail but partly conservative on full‑year trajectory. Intuitive Surgical Earnings Call Signals Robust Growth
• Negative Sentiment: The company disclosed a recent cyber incident described as contained with remediation underway — a reputational and operational risk that investors will watch for any customer or regulatory fallout. Intuitive Surgical Balances Growth In AI Surgery With Cybersecurity Lessons
• Negative Sentiment: Valuation and caution remain: several firms trimmed price targets or tempered estimates (Jefferies, TD Cowen and others adjusted targets), and some commentators warn investors not to overpay despite high‑quality growth — keeping volatility likely. TD Cowen Adjusts Price Target on Intuitive Surgical

Analyst Upgrades and Downgrades

Several research analysts have recently issued reports on ISRG shares. Robert W. Baird upped their target price on shares of Intuitive Surgical from $575.00 to $610.00 and gave the stock an “outperform” rating in a research note on Wednesday. BTIG Research reiterated a “buy” rating and issued a $574.00 target price on shares of Intuitive Surgical in a research note on Wednesday. Evercore dropped their target price on shares of Intuitive Surgical from $550.00 to $480.00 and set a “neutral” rating on the stock in a research note on Monday, April 6th. The Goldman Sachs Group lifted their target price on Intuitive Surgical from $609.00 to $621.00 and gave the stock a “buy” rating in a report on Wednesday. Finally, Jefferies Financial Group reduced their target price on Intuitive Surgical from $560.00 to $515.00 and set a “hold” rating for the company in a report on Wednesday. Eighteen research analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $586.70.

Intuitive Surgical Stock Performance

ISRG opened at $483.62 on Thursday. The stock has a market capitalization of $171.75 billion, a P/E ratio of 58.62, a P/E/G ratio of 3.52 and a beta of 1.68. The company’s 50-day simple moving average is $477.54 and its two-hundred day simple moving average is $515.41. Intuitive Surgical, Inc. has a 52-week low of $427.84 and a 52-week high of $603.88.

Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Tuesday, April 21st. The medical equipment provider reported $2.50 EPS for the quarter, topping analysts’ consensus estimates of $2.08 by $0.42. Intuitive Surgical had a net margin of 28.15% and a return on equity of 15.96%. The business had revenue of $2.77 billion during the quarter, compared to the consensus estimate of $2.62 billion. During the same quarter in the previous year, the firm posted $1.81 EPS. The firm’s revenue was up 23.0% on a year-over-year basis. Research analysts forecast that Intuitive Surgical, Inc. will post 8.16 EPS for the current fiscal year.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.